Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Total article views   HTML views PDF downloads Totals
9,428 Dovepress* 8,971+ 1,796 10,767
PubMed Central* 457 154 611
Totals 9,428 1,950 11,378
*Since 1 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar